Cincinnati Suboxone Clinics

BrightView Colerain Addiction Treatment Center

BrightView Colerain Addiction Treatment Center
6527 Colerain Ave
Cincinnati, OH 45239

Phone: 866-928-5995
Website: www.brightviewhealth.com

Medication Types
Buprenorphine
Suboxone (buprenorphine / naloxone)
Vivitrol (naltrexone)

At BrightView Colerain Addiction Treatment Center, the outpatient model of our treatment program allows our staff to develop a unique treatment plan to work with our patients’ daily life commitments and individual needs. We accept Medicaid, Medicare, and most forms of insurance to make sure that anyone battling the disease of addiction can receive our treatment services. We have caring staff who answer the phones 24-hours per day, and we provide a toll-free phone number for the convenience of our patients.

BrightView’s compassionate and professional staff create an accessible and welcoming environment for both physical and emotional healing. We are about respect for each patient, positive reinforcement, and long-term wellness. If you are looking for a patient-centered recovery center, we encourage you to take the first step in contacting us today.

 

Join Here To Have Your Medical Practice Featured in this space.
We reach thousands of prospective patients each year in search of local opioid addiction treatment services in the greater Cincinnati area.

Following payment completion, please send us the listing information you would like displayed here.

methadone8c

Cincinnati provides its residents a selection of opioid treatment options for those facing persistent withdrawal symptoms. Prescribed pain medications have evolved into a serious problem with more people having an addiction to them than heroin. With the recent increase in opiate addiction over the last 10-15 years, suboxone replacement therapy has become more sought as a primary treatment intervention to assist those trying to cope with chronic opioid withdrawal. Cincinnati offers a substantial list of authorized doctors approved to write prescriptions for suboxone. Buprenorphine is the essential ingredient in suboxone that alleviates withdrawal symptoms by binding to the brain’s opiate receptors. Suboxone is widely available across the USA based on its proven track record in eliminating opioid withdrawal. It has gained in popularity given its well-established effectiveness. If you are a local physician aiming to treat Cincinnati residents, you may purchase a featured listing at the top of this page insuring that your medical services will be found by prospective patients searching our website for quality opioid treatment.



Cincinnati Buprenorphine Suboxone Doctors
Gail M. Hellmann, M.D. 909 Sycamore Street
Suite 400
Cincinnati, OH 45202
(513) 618-4225
Robyn Fortner Chatman, M.D. 619 Oak Street
Cincinnati, OH 45206
(513) 563-6116
Kellie L. Boyd, M.D. 1420 East McMillan Avenue
Cincinnati, OH 45206
(513) 462-6773
Roslyn Seligman, M.D. 2200 Victory Parkway
Suite 602
Cincinnati, OH 45206
(513) 861-2173
Carlos Kenneth Cheng, M.D. 1019 Delta Avenue
Cincinnati, OH 45208
(513) 560-7228
Hooshang Khalily, M.D. 6725 Fair Acres Drive
Cincinnati, OH 45213
(513) 731-0896
Christine Marie Wilder, M.D. 830 Ezzard Charles Drive
Cincinnati, OH 45214
(513) 381-6672
Clifford Q. Cabansag, M.D. Center for Chemical Addictions Treatment
830 Ezzard Charles Drive
Cincinnati, OH 45214
(513) 381-6672
Jeffrey William Merling, M.D. CCAT
830 Ezzard Charles Drive
Cincinnati, OH 45214
(513) 381-6672
Esly Samuel Caldwell, M.D. 125 William Taft Road
Cincinnati, OH 45219
(513) 616-8774
Roberto R. Soria The Crossroads Center
311 Martin Luther King Drive
Cincinnati, OH 45219
(513) 475-5300
Luis Pagani, M.D. 111 Wellington Place
Cincinnati, OH 45219
(513) 241-2370
Sunny Lu, M.D. 311 Martin Luther King Drive
Cincinnati, OH 45219
(513) 475-5363
Michael A. Gureasko, M.D. 2123 Auburn Avenue
Suite 306
Cincinnati, OH 45219
(513) 281-8840
Thomas Anh Nguyen, M.D. 260 Stetson Street
Suite # 3200
Cincinnati, OH 45219
(513) 259-0027
Daniel Jason Bebo, M.D. 260 Stetson Street Suite 3200
Cincinnati, OH 45219
(513) 320-7012
Deborah L. Frankowski, M.D. University of Cincinnati Physicians
260 Stetson Street, Suite 3200
Cincinnati, OH 45219
(513) 558-7700
Lisa Margarita Fernandez, M.D. 125 William Howard Taft Road
Cincinnati, OH 45219
(513) 616-8774
James P. Cho 260 Stetson Street
Cincinnati, OH 45219
(513) 558-4731
Elliot Lee, M.D. 260 Stetson Street
Suite 3200
Cincinnati, OH 45219
(513) 558-4423
John Michael Vraciu, D.O. 2123 Auburn Avenue
Suite 310
Cincinnati, OH 45219
(513) 241-2123
Alla V. Baskakova, M.D. Cincinnati VA Medical Center
3200 Vine Street
Cincinnati, OH 45220
(513) 475-6402
Eugene C. Somoza, M.D., Ph.D VA Medical Center
3200 Vine Street, ML-151(Rsrch. Service)
Cincinnati, OH 45220
(513) 487-7800
Brooks Ryan Keeshin, M.D. 3333 Burnet Ave
Cincinnati, OH 45220
(513) 636-7233
Deborah L. Frankowski, M.D. VA Medical Center/Univ of Cincinnati
3200 Vine Street
Cincinnati, OH 45220
(513) 861-3100×5506
Anita Dilip Karnik, M.D. 3200 Vine Street
7E Sudep
Cincinnati, OH 45220
(513) 475-6402
Amelia Marie Oliva Campos, M.D. 3352 Jefferson Avenue
Cincinnati, OH 45220
(513) 399-7666
Christine Marie Wilder, M.D. Cincinnati VA Medical Center
3200 Vine Street, Room B711a
Cincinnati, OH 45220
(513) 861-3100
Arshad Javed, M.D. Uch Hospitalists
375 Dixmyth Avenue, 7th Floor
Cincinnati, OH 45220
(513) 265-0907
Soumya Lakshmi Pandalai, M.D. Cincinnati Veteran's Hospital Med Center
3200 Vine Street
Cincinnati, OH 45220
(513) 225-5451
Jennie H. Hahn, M.D. VAMC
3200 Vine Street, B703
Cincinnati, OH 45220
(513) 861-3100×5103
Osama Ali, M.D. 3200 Vine Street
7 East, Room B712
Cincinnati, OH 45220
(513) 487-6676
Richard Jeffrey Goldsmith, M.D. VA Medical Center
3200 Vine Street
Cincinnati, OH 45220
(513) 475-6402
Show Whei Lin, M.D. 3200 Vine Street
7 East
Cincinnati, OH 45220
(513) 861-3100
Tara B. Carr, M.D. 3200 Vine Street
116-A Psychiatry
Cincinnati, OH 45220
(513) 475-6325
Nabila Babar 6540 Winton Road
Cincinnati, OH 45224
(513) 541-2300
Anne C. Autry, M.D. Univ of Cincinnati, Dept. of Psychiatry
3131 Harvey Avenue
Cincinnati, OH 45229
(513) 487-7805
Naila Goldenberg, M.D. 3200 Burnet Avenue
Suite #500
Cincinnati, OH 45229
(513) 585-7800
Teresa L. Koeller, M.D. Gateways
3131 Harvey Avenue, Suite 201
Cincinnati, OH 45229
(513) 861-0035
Patrick E. McDonald, M.D. 1095 Nimitzview Drive
Suite 104
Cincinnati, OH 45230
(513) 231-4000
Cyma Khalily, M.D. 8624-A Winton Road
Cincinnati, OH 45231
(513) 522-2120
Andrea Jean Holinga, M.D. Prime Health Group, LLC
4333 East Galbraith Road
Cincinnati, OH 45236
(513) 543-6600
James T. Lutz, M.D. 8251 Pine Road
Suite 100
Cincinnati, OH 45236
(513) 241-4230
David Albert Garcia 8044 Montgomery Road
Suite 700
Cincinnati, OH 45236
(513) 545-1262
Cincinnati Suboxone Services

BrightView Cincinnati Addiction Treatment Center

BrightView Cincinnati Addiction Treatment Center
446 Morgan Street (Walnut Hills community)
Cincinnati, OH 45206

Phone: 866-928-5995
Website: www.brightviewhealth.com

Medication Types
Buprenorphine
Suboxone (buprenorphine / naloxone)
Vivitrol (naltrexone)

At BrightView Cincinnati Addiction Treatment Center, the outpatient model of our treatment program allows our staff to develop a unique treatment plan to work with our patients’ daily life commitments and individual needs. We accept Medicaid, Medicare, and most forms of insurance to make sure that anyone battling the disease of addiction can receive our treatment services. We have caring staff who answer the phones 24-hours per day, and we provide a toll-free phone number for the convenience of our patients.

BrightView’s compassionate and professional staff create an accessible and welcoming environment for both physical and emotional healing. We are about respect for each patient, positive reinforcement, and long-term wellness. If you are looking for a patient-centered recovery center, we encourage you to take the first step in contacting us today.

 


Helping Skeptics Understand Methadone

When it comes to addiction, reactions and opinions are often intense. Addiction is a devastating illness that can rapidly derail a person’s life, and seriously impact the lives of those around them.

Sadly, addiction leads people to behave in ways that make no sense to their family, friends, and co-workers. Therein lies an important part of the problem. Family feel confused, angry, and fearful as their loved one tumbles down the hill of active addiction.

When it comes to something as perplexing as drug addiction, grasping for answers is an understandable reflex for family and friends. What family often don’t comprehend is the power of physical dependency to opioids and the severe sickness that results from opioid withdrawal.

Family and others incorrectly assume that mere “choice” is all that’s needed to overcome the addiction. When the addict fails to remain drug free, harsh judgment by others usually follows.

Halting withdrawal sickness is a paramount step for an opioid addicted person. This cannot be overstated. As long as a person is suffering from severe opioid withdrawal, their ability to think and “choose” logically is greatly impaired.

Statistically, individuals who utilize medication-assisted treatment (like methadone) are far more likely to avoid incarceration, a continued downward spiral, or death by overdose. Medication assistance successfully removes debilitating withdrawal sickness so that the addicted person can experience greater clarity of thought and the ability to make more sound decisions that lead to improved quality of life.

If you are a skeptic about methadone or suboxone, you may think “they’re just trading one drug for another”. This is not true. People, once therapeutically stabilized on methadone or suboxone, do not get high from the medication. Health generally improves, and the person is able to function much better on the job and at home. This brings hope. It offers a new opportunity for further recovery.

When you care about a person’s survival, one more chance to help them can be quite valuable. Don’t let judgment or excessive skepticism get in the way. Medication-assistance in opioid recovery is effective for many people, and it has been the life saving next step that some never got the chance to take.

Posted in Methadone, Methadone Benefits, Methadone Clinics, Recovery, Suboxone | Tagged | Comments Off on Helping Skeptics Understand Methadone

Methadone Treatment in Oregon

Like most states, Oregon is in need of quality treatment options for opioid-addicted individuals who are ready for recovery.

This article, in the Hillsboro News-Times, features the recent approval by Washington County commissioners to add a new methadone clinic in Hillsboro, Oregon.

Acadia Healthcare is aiming to establish the new methadone clinic in Hillsboro in order to better serve the local community. Acadia already operate a mobile unit in the general area as well as a comprehensive treatment center (CTC) in nearby Tigard located about 20 miles away.

The commissioners voted 5-0 to approve the proposed site which will be on the local bus route thereby providing improved access. The article mentions that Oregon presently has 17 operational methadone clinics serving the state, where fentanyl, opiates, and other substances are causing a grave overdose crisis.

Having local opioid treatment available is a critically important step in saving lives and providing hope to patients and families. Methadone has been proven to decrease opioid use, reduce relapse risks & overdose deaths, as well as increase employment and overall health. Clinics offering medication-assisted treatment (MAT), like methadone and buprenorphine, are forging a new path to safety for those people once stuck in active addiction.

Posted in Acadia Healthcare, Addiction Treatment, Buprenorphine, Methadone, Methadone Clinics, Oregon Methadone Clinics, Suboxone | Tagged , , | Comments Off on Methadone Treatment in Oregon

Remote Observation of Methadone Dosing

There’s a new spin being proposed on the dispensing of methadone to Opioid Use Disorder (OUD) patients. A federally-funded project is underway between Scene Health and The University of Washington in which patients video themselves taking their daily methadone dose, and then submit that video to the treatment provider.

The project is evaluating this new modified approach that falls somewhere between in-person daily dosing and unsupervised take home dosing.

This new approach is currently being referred to as Video DOT (video direct observation therapy) and has been successfully implemented with other health issues including hepatitis C, asthma, and diabetes.

While this experiment seems appealing at first glance, it does raise legitimate questions about the ability to insure proper safety protocols with the provision of methadone medication to new patients. The project may possibly demonstrate the usefulness of Video DOT methadone dosing. But assuming this new approach one day becomes common practice, it will be important that physicians or clinics have in place a procedure for quickly reclaiming methadone doses that are not ingested on schedule.

Imagine a new patient receives 7 take home doses of methadone, but then only sends in the required video of their medication use on day one. At what point does the prescribing clinic intervene, and how will the unaccounted for doses be retrieved?

Approved Opioid Treatment Programs currently have “callback” procedures in which stable patients are randomly selected to return to their home clinic with their unused take home doses. This allows the clinic medical staff to perform a medication count, and it acts as a safeguard to insure patients are taking their medication as prescribed.

Patients who have earned take home privileges through months of treatment progress are less inclined to divert or misuse methadone than someone who just started treatment. New patients must be inducted gradually on a stabilizing dose of methadone. And time is typically needed to help these patients adjust to methadone while eliminating use of all other illicit substances. This is where the benefit of a structured treatment program is most relevant. OTP’s provide extremely valuable life management skills training in conjunction with medication therapy.

It remains to be seen if “easy access” to methadone is truly an advancement in care, or a step backwards in accountability & safety for patients and the public.

Posted in Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Programs, Suboxone, Suboxone Clinics | Tagged | Comments Off on Remote Observation of Methadone Dosing

Expanding Access to Methadone

Historically, access to methadone for the treatment of opioid addiction has been through enrollment in a local clinic licensed to dispense methadone. As a result of Covid restrictions, some of these clinic regulations were relaxed. For example, many patients across the U.S. were allowed to begin receiving take home doses of methadone as a result of Covid lockdowns and decreased clinic access.

Critics have begun to express the belief that clinic restrictions are cumbersome and that methadone should be made available for pick-up at local pharmacies. On the other hand, the concern remains that methadone can be misdirected or mishandled thus reinforcing the need for close supervision, particularly in the early phases of opioid treatment. Decades of research has shown that taken under proper supervision, methadone’s safety profile is excellent.

In this recent era of contaminated street opiates and overdose concerns, it is clear that methadone is a phenomenally effective medication for promoting health, well-being, and physical safety.

Mark Parrino, president of the American Association for the Treatment of Opioid Dependence, recently shared that deregulation of methadone would likely increase the diversion of methadone and methadone-related overdose deaths.

Following a period of stability, most U.S. clinics do allow patients to begin dosing at home with methadone. This system of care is working well throughout the country where methadone is readily available. However, many U.S. citizens are still lengthy distances from methadone-approved clinics. So, the challenge continues to link those with opioid addiction to effective resources in their local community. Legislators are presently examining a range of options as the opioid epidemic marches on.

Posted in Acadia Healthcare, Addiction Treatment, Brightview, Methadone, Methadone Clinics, Opioid Treatment, Suboxone | Tagged | Comments Off on Expanding Access to Methadone

 
Over the last 10 years, opioid use disorder has emerged as a primary medical problem in the United States. Individuals from varied and diverse backgrounds have all been subject to the dangers of opioid misuse and potential opioid dependency. The good news is that addiction is a treatable illness. And with opioid addiction in particular, there are specific medication-assisted interventions available that have proven successful. Extensive research studies have shown the clear benefits of both methadone and buprenorphine (suboxone) in alleviating the debilitating physical symptoms of opioid withdrawal.